Zeta Global CEO to Purchase $3M in Company Stock

Zeta Global (NYSE: ZETA) has announced that its co-founder, chairman, and CEO, David A. Steinberg, alongside members of the company's leadership and board of directors, intends to purchase shares of Zeta's Class A common stock on Monday, November 18, 2024. The intended purchases by Steinberg, other members of Zeta's leadership, and the directors collectively represent approximately $3 million of Zeta's Class A common stock.

Steinberg expressed confidence in the company's integrity by making these purchases, following what he referred to as a "report" filled with false claims and objectively wrong information about Zeta Global. He emphasized that the board, company leadership, and himself are committed to not allowing untrue claims to derail the company's forward momentum, which has delivered strong results for shareholders over the last three years.

Steinberg further stated his belief that the current share price is undervalued and expressed optimism about the company's future.

Zeta Global, a leading AI-powered marketing cloud, aims to make sophisticated marketing simple by leveraging advanced artificial intelligence and trillions of consumer signals to help marketers acquire, grow, and retain customers more efficiently. The Zeta Marketing Platform (ZMP) unifies identity, intelligence, and omnichannel activation into a single platform, powered by one of the industry's largest proprietary databases and AI. The company's enterprise customers across multiple verticals are empowered to personalize experiences with consumers at an individual level across every channel, delivering better results for marketing programs.

Zeta Global was founded in 2007 by David A. Steinberg and John Sculley and is headquartered in New York City, with offices around the world. Today the company's shares have moved 5.4% to a price of $18.52. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS